ADMA logo

ADMA
Adma Biologics Inc

20,365
Mkt Cap
$4.12B
Volume
564.00
52W High
$25.67
52W Low
$13.50
PE Ratio
20.32
ADMA Fundamentals
Price
$17.30
Prev Close
$17.01
Open
$16.96
50D MA
$18.40
Beta
1.28
Avg. Volume
2.34M
EPS (Annual)
$0.8123
P/B
9.56
Rev/Employee
$622,560.58
Loading...
Loading...
News
all
press releases
ADMA Biologics Inc $ADMA Shares Sold by Lisanti Capital Growth LLC
Lisanti Capital Growth LLC lessened its position in shares of ADMA Biologics Inc (NASDAQ:ADMA - Free Report) by 71.1% during the 3rd quarter, according to the company in its most recent 13F filing...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?
Based on the average brokerage recommendation (ABR), Adma Biologics (ADMA) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Zacks·4d ago
News Placeholder
ADMA Biologics Enters Oversold Territory (ADMA)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Nasdaq News: Markets·5d ago
News Placeholder
Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know
Adma Biologics (ADMA) concluded the recent trading session at $16.96, signifying a +1.37% move from its prior day's close.
Zacks·7d ago
News Placeholder
ADMA Gains 13.8% in Three Months: More Upside Potential for 2026?
ADMA shares rose 13.8% over three months as demand for Asceniv surged, driving higher 2026 revenues and EBITDA targets amid margin expansion.
Zacks·11d ago
News Placeholder
Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know
Adma Biologics (ADMA) concluded the recent trading session at $17.59, signifying a +1.62% move from its prior day's close.
Zacks·13d ago
News Placeholder
Campbell & CO Investment Adviser LLC Purchases Shares of 64,535 ADMA Biologics Inc $ADMA
Campbell & CO Investment Adviser LLC acquired a new stake in ADMA Biologics Inc (NASDAQ:ADMA - Free Report) during the 3rd quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·13d ago
News Placeholder
Adma Biologics (ADMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest trading session, Adma Biologics (ADMA) closed at $17.7, marking a -1.28% move from the previous day.
Zacks·20d ago
News Placeholder
ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 Outlook
ADMA expects 2025 revenues of approximately $510-$511 million, raising 2026 guidance on strong Asceniv demand and margin expansion.
Zacks·20d ago
News Placeholder
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?
The average brokerage recommendation (ABR) for Adma Biologics (ADMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Zacks·20d ago
<
1
2
...
>

Latest ADMA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.